An Experimental Generator for Production of High-Purity (212)Pb for Use in Radiopharmaceuticals

por Li, Ruth Gong, Stenberg, Vilde Yuli, Larsen, Roy Hartvig
Publicado 2023

Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer

por Juzeniene, Asta, Stenberg, Vilde Yuli, Bruland, Øyvind Sverre, Larsen, Roy Hartvig
Publicado 2021

Dual targeting with (224)Ra/(212)Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach

por Juzeniene, Asta, Stenberg, Vilde Yuli, Bruland, Øyvind Sverre, Revheim, Mona-Elisabeth, Larsen, Roy Hartvig
Publicado 2023

Evaluation of the PSMA-Binding Ligand (212)Pb-NG001 in Multicellular Tumour Spheroid and Mouse Models of Prostate Cancer

por Stenberg, Vilde Yuli, Larsen, Roy Hartvig, Ma, Li-Wei, Peng, Qian, Juzenas, Petras, Bruland, Øyvind Sverre, Juzeniene, Asta
Publicado 2021

Targeted alpha therapy with the (224)Ra/(212)Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma

por Tornes, Anna Julie Kjøl, Stenberg, Vilde Yuli, Larsen, Roy Hartvig, Bruland, Øyvind Sverre, Revheim, Mona-Elisabeth, Juzeniene, Asta
Publicado 2022

Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand (212)Pb-NG001

por Stenberg, Vilde Yuli, Tornes, Anna Julie Kjøl, Nilsen, Hogne Røed, Revheim, Mona-Elisabeth, Bruland, Øyvind Sverre, Larsen, Roy Hartvig, Juzeniene, Asta
Publicado 2022